Intech Investment Management LLC reduced its holdings in Ashland Inc. (NYSE:ASH – Free Report) by 43.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,558 shares of the basic materials company’s stock after selling 5,859 shares during the period. Intech Investment Management LLC’s holdings in Ashland were worth $540,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Raymond James Trust N.A. lifted its stake in shares of Ashland by 5.5% in the 3rd quarter. Raymond James Trust N.A. now owns 3,104 shares of the basic materials company’s stock valued at $270,000 after purchasing an additional 163 shares during the period. Vontobel Holding Ltd. lifted its stake in Ashland by 11.4% in the fourth quarter. Vontobel Holding Ltd. now owns 3,541 shares of the basic materials company’s stock valued at $253,000 after buying an additional 362 shares during the period. Synovus Financial Corp lifted its stake in Ashland by 11.2% in the third quarter. Synovus Financial Corp now owns 3,964 shares of the basic materials company’s stock valued at $345,000 after buying an additional 400 shares during the period. Victory Capital Management Inc. boosted its holdings in Ashland by 2.8% during the fourth quarter. Victory Capital Management Inc. now owns 15,429 shares of the basic materials company’s stock worth $1,103,000 after buying an additional 417 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in shares of Ashland during the 3rd quarter worth about $38,000. 93.95% of the stock is owned by institutional investors.
Insiders Place Their Bets
In related news, CEO Guillermo Novo bought 31,294 shares of the company’s stock in a transaction that occurred on Friday, January 31st. The shares were acquired at an average price of $64.24 per share, for a total transaction of $2,010,326.56. Following the completion of the acquisition, the chief executive officer now owns 31,294 shares of the company’s stock, valued at approximately $2,010,326.56. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.02% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on ASH
Ashland Stock Up 1.4 %
ASH stock opened at $57.24 on Tuesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.52 and a quick ratio of 1.27. The stock has a market capitalization of $2.70 billion, a P/E ratio of -86.72, a P/E/G ratio of 1.14 and a beta of 0.89. Ashland Inc. has a fifty-two week low of $54.86 and a fifty-two week high of $102.50. The business has a 50-day moving average of $63.47 and a 200-day moving average of $74.29.
Ashland (NYSE:ASH – Get Free Report) last released its quarterly earnings results on Tuesday, January 28th. The basic materials company reported $0.28 earnings per share for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.51). Ashland had a positive return on equity of 7.41% and a negative net margin of 1.12%. During the same period last year, the company posted $0.45 EPS. On average, sell-side analysts anticipate that Ashland Inc. will post 4.27 earnings per share for the current fiscal year.
Ashland Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Saturday, March 15th. Shareholders of record on Saturday, March 1st were paid a $0.405 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.62 annualized dividend and a yield of 2.83%. Ashland’s payout ratio is currently -245.45%.
Ashland Profile
Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.
Further Reading
- Five stocks we like better than Ashland
- Investing In Automotive Stocks
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- How to trade penny stocks: A step-by-step guide
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- What is the FTSE 100 index?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Ashland Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashland and related companies with MarketBeat.com's FREE daily email newsletter.